Patient Characteristics | Total, N (%) | Late referrala, n (%) | Intermediate referrala, n (%) | Early referrala, n (%) |
---|---|---|---|---|
Number of patients | 281 (100) | |||
Patients died | 227 (80.1) | 115 (50.7) | 82 (36.1) | 30 (13.2) |
Gender | 281 | 115 | 82 | 30 |
Male | 116 (41.3) | 54 (47.0) | 35 (42.7) | 6 (20.0) |
Female | 165 (58.7) | 61 (53.0) | 47 (57.3) | 24 (80.0) |
Age at first presentation, in years | ||||
Mean ± SD | 61.54 (12.13) | 62.65 (11.95) | 60.55 (14.103) | 60.33 (10.694) |
Median (range) | 62 (18–88) | 63 (30–87) | 62 (18–88) | 59 (28–80) |
Site of primary tumor | 281 | 115 | 82 | 30 |
Gastrointestinal tract | 72 (25.6) | 35 (30.4) | 22 (26.8) | 4 (13.3) |
Lung | 62 (22.1) | 31 (27.7) | 18 (22.0) | 6 (20.0) |
Breast | 49 (17.4) | 15 (13.0) | 14 (17.1) | 12 (40.0) |
Sarcoma | 41 (14.6) | 15 (13.0) | 11 (13.4) | 3 (10.0) |
Genitourinary | 16 (5.7) | 7 (6.3) | 2 (2.4) | 0 |
Head and neck | 15 (5.3) | 4 (3.6) | 6 (7.3) | 2 (6.7) |
Other gynaecologic | 8 (2.8) | 3 (2.7) | 2 (2.4) | 1 (3.3) |
Othersb | 18 (6.4) | 5 (4.5) | 7 (8.5) | 2 (6.7) |
Months after first metastasis | ||||
Mean ± SD | 29.16 (37.27) | 24.98 (31.285) | 25.09 (28.515) | 39.76 (55.912) |
Median (range) | 15.5 (-48–222) | 15 (-2–222) | 15 (-9–143) | 16 (-48–200) |
Chemotherapy at time of first referral | 281 | 115 | 82 | 30 |
Yes | 189 (67.3) | 75 (65.2) | 63 (76.8) | 23 (76.7) |
No | 92 (32.7) | 40 (34.8) | 19 (23.2) | 7 (23.3) |
Chemotherapy line | 281 | 115 | 82 | 30 |
1st | 74 (26.3) | 19 (16.5) | 24 (29.3) | 12 (40.0) |
2nd | 73 (26.0) | 28 (24.3) | 27 (32.9) | 6 (20.0) |
3rd | 46 (16.4) | 32 (27.8) | 8 (9.8) | 1 (3.3) |
> 3rd | 45 (16.0) | 23 (20.0) | 13 (15.9) | 6 (20.0) |
None | 43 (15.3) | 13 (11.3) | 10 (12.2) | 5 (16.7) |